Positions

Professor and Chief, Section of Breast Surgery

Division of Surgical Oncology
Section of Breast Surgery
Baylor College of Medicine

Co-Director, Lester and Sue Smith Breast Center

Dan L Duncan Comprehensive Cancer Center

Olga Keith Wiess Chair of Surgery

Baylor College of Medicine

Co-Associate Director for Clinical research

Dan L Duncan Comprehensive Cancer Center

Addresses

Dan L Duncan Comprehensive Cancer Center (Clinic)

O’Quinn Medical Tower at Baylor St. Luke’s Medical Center’s McNair Campus
1919 Old Spanish Trail
Houston, TX 77054
United States
Phone: (832) 957-6500
Interactive Map

Education

Residency at Royal Infirmary of Edinburgh

Edinburgh

General Surgery

Research Fellowship at Imperial Cancer Research Fund

Edinburgh

MD from University of Edinburgh

Edinburgh

Molecular Biology

MBChB from University of Edinburgh

Edinburgh

Medicine Surgery

BSc from University of Edinburgh

Edinburgh

Medical Science Anatomy

Honors & Awards

James IV Association of Surgeons Travelling Fellowship

James IV Association

King James IV Professorship in Surgery

Royal College of Surgeons of Edinburgh

Lister Prize for Surgery

University of Edinburgh

William Leslie Prize for Surgery

University of Edinburgh

Director's Service Award

National Cancer Institute

2017 Top Performer

Top 1% Performer Consumer Assessment of Healthcare Providers and Systems (CAHPS) Measure.

Professional Interests

• Ductal Carcinoma In Situ (DCIS)
• Nipple and Skin Sparing Mastectomy
• Breast Conservation Surgery
• Breast Surgery
• Surgical Oncology
• Sentinel Lymph Node Biopsy
• Mastectomy
• Translational research
• Clinical trials
• Patient outcomes

Professional Statement

Over the last 35 years, Professor Thompson has trained and practiced as a clinician-scientist focused on multidisciplinary patient care alongside translational “bench to bedside” studies and innovative clinical trials in cancer. He initiated and lead a successful breast cancer laboratory program, provided leadership for a cancer center in the United Kingdom (UK), chaired the UK national breast cancer trials portfolio of 120 studies and engaged in a range of pivotal roles in key drug, radiation therapy and surgical trials involving the UK, Europe, the United States and Australia. Since moving to the US in 2014, he has specialized in improving treatment for breast cancer patients with innovative localization techniques for breast conservation and axillary node surgery and to minimize patient impact through to skin sparing and nipple sparing mastectomy with autologous reconstruction where required.
Unusually for a surgeon, Professor Thompson has preclinical and practical experience in the design, implementation, monitoring and reporting of early through to late phase drug and medical device trials. Recent pharmaceutical experience includes active leadership of international trials such as the SOLE, MA32, MINDACT, and KRISTINE trials; He currently chairs several phase II and phase III data monitoring committees and trials steering groups. For radiotherapy, he co-authored the ASTRO ABPI consensus guidelines and has contributed to intraoperative and hypofractionation trials. Since transitioning to the US, national leadership roles include co-chairing the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for low risk DCIS, co-chairing the NCI-BCSC proposed “no surgery” clinical trial planning committee and membership of the NCI BOLD taskforce and leadership positions within TBCRC (Loco-regional Subgroup co-Chair) and SWOG (Translational Medicine Breast Group Chair). Professor Thompson is an active member of ASCO, SSO, ASBrS and AACR.
With successful peer reviewed funding from US government and international charitable sources linking laboratory to clinical studies, successful supervision of 24 postgraduate students and some 350 peer reviewed publications in the highest impact factor clinical and scientific journals, improved care of those with cancer is his key mission.

Websites

Videos

Selected Publications

• Maetens M, Brown D, Irrthum A, Aftimos P, Viale G, Loibl S, Laes JF, Campbell PJ, Thompson A, Cortes J, Seiler S, Vinnicombe S, Oliveira M, Rothé F, Bareche Y, Fumagalli D, Zardavas D, Desmedt C, Piccart M, Loi S, Sotiriou C "The AURORA pilot study for molecular screening of patients with advanced breast cancer-a study of the breast international group." NPJ Breast Cancer.;
• Maxwell AJ, Clements K, Hilton B, Dodwell DJ, Evans A, Kearins O, Pinder SE, Thomas J, Wallis MG, Thompson AM "Risk Factors for The Development of Invasive Cancer in Unresected Ductal Carcinoma In Situ." European Journal of Surgical Oncology.;
• Rosso KJ, Weiss A, Thompson AM "Are There Alternative Strategies for the Local Management of Ductal Carcinoma in Situ?." Surg Oncol Clin N Am.;
• Grimm LJ, Ryser MD, Partridge AH, Thompson AM, Thomas JS, Wesseling J, Hwang ES "Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials." Ann Surg Oncol.; Pubmed PMID: 28795370

Memberships

American Association of Cancer Research

American Society of Clinical Oncology

British Breast Group

Moynihan Chirurgical Club

Association of Breast Surgery

British Association of Surgical Oncology

American Society of Breast Surgeons

Society of Surgical Oncology

Intellectual Property

Method Patent #PD2011A000201

Del Sal G, Napoli M, Girardini BJE, Piazza S, Thompson A, Method for prognosis of tumours of the breast Pin1 in combination with mutation in the gene p53, Italy, Industrial Invention PD2011A000201

Method Patent

Hardie G, Thompson AM, Hadad S, Method for diagnosing cancer using pAMPK, United States, No 61, Filed